ArticleDiabetes research and clinical practice2022

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.

Frauke Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.